IGC PHARMA INC

IGCNYSE AMERICAN

🏆 #3593 by market capEarnings Aug 12US Equity

$919.56▼ $33.38 (−3.63%)

Simulated price

1h—

24h▼ 3.6%

7d—

14d—

30d—

1y—

🏦Market Cap

$27M

Small Cap

📈Revenue Growth (YoY)

-6.7%

Declining

📊Gross Margin

29.7%

Moderate

💵FCF Margin

22.8%

Strong

⚖️P/S Ratio

22.8x

Expensive

Otter Score

48

Weak

Earnings

Q1 · 2026Reported 2025-06-30

Earnings Per Share

Actual

-0.02

Expected

-0.02

beat

+14.20%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q1 2026

-0.02

beat

Q4 2025

-0.01

beat

Q3 2025

-0.02

beat

Q2 2025

-0.02

beat